About Crelux
Crelux is a company based in Planegg (Germany) founded in 2005 was acquired by WuXi AppTec in April 2016. Crelux offers products and services including CRELUX Protein, X-ray Crystallography, Cryo-EM, Biophysics and Biochemistry, and Fragment Screening and FBDD. Crelux operates in a competitive market with competitors including Proteros, Nabla, Biomatter, Syrrx and Fina Biosolutions, among others.
- Headquarter Planegg, Germany
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Crelux Solutions Gmbh
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$862.78 K (USD), Grant
Apr 01, 2015
-
Investors
WuXi AppTec
& 1 more
-
Employee Count
Not available
-
Acquired by
WuXi AppTec
(Apr 15, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Crelux
Crelux offers a comprehensive portfolio of products and services, including CRELUX Protein, X-ray Crystallography, Cryo-EM, Biophysics and Biochemistry, and Fragment Screening and FBDD.
Service for supplying high-quality proteins to expedite drug discovery projects.
Off-the-shelf service for early-stage drug discovery and fragment screening.
Gene-to-structure service supporting drug discovery through advanced imaging.
Platform for target validation and hit confirmation in drug development.
Technology for hit finding and lead optimization in pharmaceutical research.
People of Crelux
Unlock access to complete
Unlock access to complete
Funding Insights of Crelux
Investors in Crelux
Crelux has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include WuXi AppTec and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked | |
|
Provider of CRO and CDMO services
|
Locked | Locked | Locked |
Investor details for Crelux
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Crelux
Investment portfolio details for Crelux
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Crelux
Detailed financials for Crelux
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Crelux Comparisons
Peer comparison for Crelux
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Crelux
Crelux operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Proteros, Nabla, Biomatter, Syrrx and Fina Biosolutions, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Drug discovery services are provided to researchers in protein biochemistry.
|
|
| Locked | Locked | Locked |
Synthetic biology platform for functional protein identification is provided.
|
|
| Locked | Locked | Locked |
Provider of synthetic biology and AI-based technology for generative protein design
|
|
| Locked | Locked | Locked |
Provider of drug targets research and clinical trial services
|
|
| Locked | Locked | Locked |
Biotechnology company specializing in bioconjugation services mainly for vaccine development
|
|
| Locked | Locked | Locked |
Protein expression, purification, and structural biology services are provided.
|
Detailed competitors of Crelux
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Crelux
Complete news archive for Crelux
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Crelux
Crelux was founded in 2005 and raised its 1st funding round 10 years after it was founded.
Crelux is headquartered in Planegg, Germany. It is registered at Planegg, Bavaria, Germany.
Crelux was founded in 2005 in Planegg, Germany, as a provider of solutions for early-stage drug development within the biotechnology sector. Expertise is focused on protein production, biophysical screening, and X-ray crystallography. Services encompass hit-finding, validation, optimization technologies, and protein biochemistry, marketed under brands such as PRIME PROTEINS, XPRESS, XPERTXPEDITE, and INTRACT. Operations support research partnerships globally.
Crelux offers CRELUX Protein, X-ray Crystallography, Cryo-EM, Biophysics and Biochemistry, and Fragment Screening and FBDD.
Crelux has 2 investors. Key investors include WuXi AppTec, and European Union.